Susquehanna International Group, LLP Corbus Pharmaceuticals Holdings, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $5.46 $7,054 - $350,155	64,131 Added 68.75%	157,406 $17,000
Q3 2022 Nov 14, 2022	SELL	$0.17 - $5.31 $595 - $18,590	-3,501 Reduced 3.62%	93,275 $15,000
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $124,281 - $313,663	-591,818 Reduced 85.95%	96,776 $24,000
Q1 2022 May 16, 2022	SELL	$0.32 - $0.67 $172,679 - $361,546	-539,622 Reduced 43.94%	688,594 $366,000
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $183,035 - $338,615	305,059 Added 33.05%	1,228,216 $756,000
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.82 $249,681 - $449,920	247,209 Added 36.57%	923,157 $942,000
Q2 2021 Aug 11, 2021	SELL	$1.39 - $2.21 $683,592 - $1.09 Million	-491,793 Reduced 42.11%	675,948 $1.24 Million
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $648,934 - $1.75 Million	510,972 Added 77.8%	1,167,741 $2.3 Million
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $8,661 - $17,414	-9,214 Reduced 1.38%	656,769 $821,000
Q3 2020 Nov 16, 2020	BUY	$1.5 - $9.38 $950,166 - $5.94 Million	633,444 Added 1946.72%	665,983 $1.2 Million
Q2 2020 Aug 14, 2020	SELL	$4.79 - $8.39 $798,445 - $1.4 Million	-166,690 Reduced 83.67%	32,539 $273,000
Q1 2020 May 15, 2020	SELL	$3.44 - $7.21 $416,601 - $873,167	-121,105 Reduced 37.81%	199,229 $1.04 Million
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $1.26 Million - $1.66 Million	293,619 Added 1099.08%	320,334 $1.75 Million
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $903,774 - $1.31 Million	-185,580 Reduced 87.42%	26,715 $130,000
Q2 2019 Aug 16, 2019	BUY	$6.6 - $7.8 $52,595 - $62,158	7,969 Added 3.9%	212,295 $1.47 Million
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $492,973 - $582,605	74,693 Added 57.62%	204,326 $1.42 Million
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $482,094 - $749,088	83,697 Added 182.2%	129,633 $901,000
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $41,154 - $62,357	7,824 Added 20.53%	45,936 $268,000
Q3 2018 Nov 14, 2018	SELL	$4.65 - $7.95 $141,564 - $242,029	-30,444 Reduced 44.41%	38,112 $288,000
Q2 2018 Aug 14, 2018	SELL	$5.05 - $6.8 $510,736 - $687,724	-101,136 Reduced 59.6%	68,556 $346,000
Q1 2018 May 15, 2018	BUY	$5.6 - $9.25 $48,361 - $79,883	8,636 Added 5.36%	169,692 $1.04 Million
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $1.06 Million - $1.25 Million	161,056	161,056 $1.14 Million

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$559,757
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$44,016
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$38,402
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account